Drug combinations with quercetin: doxorubicin plus quercetin in human breast cancer cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Drug combinations with quercetin: doxorubicin plus quercetin in human breast cancer cells

Published:2011-03-13 Issue:5 Volume:68 Page:1161-1172
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Staedler Davide,Idrizi Elita,Kenzaoui Blanka Halamoda,Juillerat-Jeanneret Lucienne

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-011-1596-x.pdf

Reference42 articles.

1. Hortobagyi GN (1998) Treatment of breast cancer. N Engl J Med 339:974–984

2. Andreetta C, Minisini AM, Miscoria M, Puglisi F (2010) First-line chemotherapy with or without biologic agents for metastatic breast cancer. Crit Rev Oncol Hematol 76:99–111

3. Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L (2004) Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev 56:185–229

4. Gajewski E, Gaur S, Akman SA, Matsumoto L, van Balgooy JN, Doroshow JH (2007) Oxidative DNA base damage in MCF-10A breast epithelial cells at clinically achievable concentrations of doxorubicin. Biochem Pharmacol 73:1947–1956

5. Adlercreutz H, Mousavi Y, Hockerstedt K (1992) Diet and breast cancer. Acta Oncol 31:175–181

Cited by 128 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mitigating Doxorubicin-Induced Cardiotoxicity through Quercetin Intervention: An Experimental Study in Rats;Antioxidants;2024-08-31

2. Quercetin inhibits breast cancer cell proliferation and survival by targeting Akt/mTOR/PTEN signaling pathway;Chemical Biology & Drug Design;2024-06

3. Recent advancements in natural compounds for cancer therapy and prevention;Phytochemistry Reviews;2024-03-28

4. A Glance at the Effects of Secondary Metabolites in Fighting Cancer;Interdisciplinary Cancer Research;2024

5. The anticancer mechanism of action of selected polyphenols in triple-negative breast cancer (TNBC);Biomedicine & Pharmacotherapy;2023-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3